- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00793234
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery
Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery: A Dose-Escalating, Multicenter, Randomised, Active- Controlled Open Label Study
연구 개요
상세 설명
Currently available anticoagulant therapies for the prevention of VTE include low molecular weight heparins, pentasaccharides and vitamin K antagonists, all of which have inherent limitations(1-3).
Improved anticoagulant agents are therefore required(4). A novel antithrombotic agent requires demonstration of both efficacy and safety in relevant populations. Phase II studies are frequently performed in patients undergoing total hip replacement and/or total knee replacement because of the high and well documented incidence of deep vein thrombosis in the absence of adequate thromboprophylaxis(5-7).
In this study, we assess the safety and efficacy of TB-402, a novel antithrombotic agent that partially inhibits factor VIII, in the prevention of VTE in patients undergoing total knee replacement surgery.
연구 유형
등록 (실제)
단계
- 2 단계
연락처 및 위치
연구 장소
-
-
-
Liepāja, 라트비아, LV-3400
- Ltd "Liepajas regionala slimnica"
-
Riga, 라트비아, LV-1005
- Ltd "Traumatologijas un ortopedijas slimnica"
-
Valmiera, 라트비아, LV 4201
- Vidzemes slimnica
-
-
-
-
-
Cheliabinsk, 러시아 연방, 454136
- Municipal Healthcare Institution "City Clinical Hospital No. 3"
-
Moscow, 러시아 연방, 111539
- Moscow State Healthcare Institution "City Clinical Hospital No. 15 n.a. O.M. Filatov"
-
Orenburg, 러시아 연방, 460000
- Municipal Healthcare Institution "City Clinical Hospital No. 4"
-
Saint Petersburg, 러시아 연방, 194291
- Federal State Medical Institution: Clinical Hospital #122 named after L.G. Sokolov under the Federal Medical-Biological Agency
-
Saint Petersburg, 러시아 연방, 194354
- Saint Petersburg State Healthcare Institution "Municipal Multi-Speciality Hospital No. 2"
-
Saint Petersburg, 러시아 연방, 197046
- Federal State Institution "Russian Research Institute of Traumatology and Orthopedics n.a. R.R. Vreden under the Federal Authority for Healthcare and Social Development"
-
Saint-Petersburg, 러시아 연방, 193312
- Saint Petersburg State Healthcare Institution "Aleksandrovskaya Hospital"
-
Samara, 러시아 연방, 443095
- State Healthcare Institution "Samara Regional Clinical Hospital n.a. M.I. Kalinin"
-
-
-
-
-
Bucuresti, 루마니아, 042122
- Spitalul Clinic de Urgenta Sf. Ioan Bucuresti
-
Cluj - Napoca, 루마니아, 400132
- Spitalul Clinic de Urgenta Prof. Dr. Octavian Fodor CLUJ NAPOCA
-
Craiova, 루마니아, 200642
- Spitalul Clinic Judetean de Urgenta Craiova
-
-
-
-
-
Pleven, 불가리아, 5800
- SHAT of orthopedics, traumatology and surgery "Sv. Pantaleimon " - Pleven Department of Orthopaedics and Traumatology
-
Plovdiv, 불가리아, 4002
- Dept. of Orthopedics, UMHAT "Saint George"
-
Rousse, 불가리아, 7002
- MHAT Rousse
-
Sofia, 불가리아, 1709
- MHAT "Sveta Anna" AD - Sofia, Clinic of Orthopedics and Traumatology
-
Varna, 불가리아, 9000
- MHAT "Sv. Anna", Department of Orthopaedics and Traumatology
-
-
-
-
-
Cherkassy, 우크라이나, 18009
- Cherkasska Regional Hospital. Department of Orthopedics and Traumatology.
-
Ivano-Frankivsk, 우크라이나, 76008
- Ivano-Frankіvsk Regional Clinical Hospital, Department of ortopedics and traumatology.
-
Odessa, 우크라이나, 65025
- Odessa Regional Clinical Hospital, Department of Orthopedics and Traumatology
-
-
-
-
-
Beer - Sheva, 이스라엘, 84101
- Soroka MC
-
Beer-Yaakov, 이스라엘, 70300
- Asaf Harofeh MC
-
Haifa, 이스라엘, 31096
- Rambam MC
-
Jerusalem, 이스라엘, 91031
- Shaare Zedek Mc
-
Kfar Saba, 이스라엘, 44281
- Meir Medical Center (MC)
-
Petach Tikva, 이스라엘, 49100
- Beilinson Hospital
-
Rehovot, 이스라엘, 76100
- Kaplan MC
-
Tel Aviv, 이스라엘, 64239
- Sourasky MC
-
-
-
-
-
Bydgoszcz, 폴란드, 85-094
- Szpital Uniwersytecki im. dr. Antoniego Jurasza w Bydgoszczy Klinika Ortopedii i Traumatologii Narządu Ruchu
-
Kraków, 폴란드, 31-826
- Wojewódzki Szpital Specjalistyczny im. L. Rydygiera w Krakowie, Oddział Kliniczny Ortopedii i Traumatologii Narządu Ruchu
-
Lubuskie, 폴란드, 20-090
- Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Katedra i Klinika Ortopedii Traumatologii i Rehabilitacji
-
Podlaski, 폴란드, 15-276
- Uniwersytecki Szpital Kliniczny w Białymstoku, Klinika Ortopedii i Traumatologii
-
Warszawa, 폴란드, 03-242
- Wojewódzki Szpital Bródnowski Samodzielny Publiczny Zakład Opieki Zdrowotnej, Oddział Chirurgii Urazowo-Ortopedycznej i Rehabilitacji
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Male or female patients aged > 18 and < 80 years old
- Female patients should be post menopausal
- Patients undergoing primary elective total knee replacement surgery
- Written informed consent obtained from the patient (or a legally acceptable representative) prior to inclusion in the study
- Willing and able to comply with scheduled visits, treatment plan, laboratory tests and other study procedures
Exclusion Criteria:
- Body weight < 50 kg or > 100 kg
- Patients undergoing a hemiarthroplasty, surface repair or revisionary surgery of the knee
- Confirmed symptomatic deep vein thrombosis or pulmonary embolism within the past year
- Anticipated use of indwelling intrathecal or epidural catheter for more than 4 h after surgery or during the entire study
- Uncontrolled hypertension (SBP>160 mm Hg or DBP > 100 mm Hg)
- History of intracranial or intraocular bleeding. History of gastrointestinal and/or endoscopically verified ulcer disease within the past year
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
활성 비교기: 4
|
Enoxaparin 40mg/day sc injection for at least 10 days post-surgery
|
실험적: 1
0.3 mg/kg TB-402
|
TB-402 administered as single bolus 18-24 post total knee replacement surgery.
|
실험적: 2
0.6 mg/kg TB-402
|
TB-402 administered as single bolus 18-24 post total knee replacement surgery.
|
실험적: 3
1.2 mg/kg TB-402
|
TB-402 administered as single bolus 18-24 post total knee replacement surgery.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
The occurrence of total bleeding defined as major and/or clinically relevant non-major bleeding events, from randomisation until the end of the study.
기간: All visists from randomization to end of study
|
All visists from randomization to end of study
|
Composite of the occurrence of asymptomatic DVT as detected by bilateral venography and symptomatic VTE, i.e. DVT or fatal or non-fatal PE.
기간: Prior to hospital discharge Day 7-11
|
Prior to hospital discharge Day 7-11
|
2차 결과 측정
결과 측정 |
기간 |
---|---|
Incidence of major bleeding events
기간: All visists from randomization to end of study
|
All visists from randomization to end of study
|
Incidence of clinically significant non-major bleeding events
기간: All visits from randomization to end of study
|
All visits from randomization to end of study
|
Incidence of minor bleeding events
기간: All visits from randomization to end of study
|
All visits from randomization to end of study
|
Incidence of all cause mortality
기간: All visits from randomization to end of study
|
All visits from randomization to end of study
|
Incidence of adverse events
기간: All visists from randomization to end of study
|
All visists from randomization to end of study
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
TB-402에 대한 임상 시험
-
ThromboGenicsBioInvent International AB완전한
-
University of OxfordCrucell Holland BV; University of Birmingham; Emergent BioSolutions; Aeras완전한
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.완전한
-
Reata, a wholly owned subsidiary of Biogen종료됨
-
Assistance Publique - Hôpitaux de Paris완전한
-
Yale UniversityNational Institutes of Health (NIH)아직 모집하지 않음